sb 203580 has been researched along with Signet Ring Cell Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukui, Y; Ihara, S; Karouji, Y; Kobayashi, M; Konishi, H; Xu, Q | 1 |
1 other study(ies) available for sb 203580 and Signet Ring Cell Carcinoma
Article | Year |
---|---|
The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.
Topics: Adenocarcinoma; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Signet Ring Cell; Cell Communication; Cell Differentiation; Chromones; Humans; Imidazoles; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morpholines; Mucin-1; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Pyridines; rac GTP-Binding Proteins | 2003 |